On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....